Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.
Guosheng Xu,Dongsheng Guo,Feima Wu,Nasir Abbas,Keyu Lai,Fang Yuan,Kai You,Yanli Liu,Yuanqi Zhuang,Yuhang Wu,Yingying Xu,Yan Chen,Fan Yang,Tingcai Pan,Yin-Xiong Li
DOI: https://doi.org/10.1016/j.scr.2017.12.009
IF: 1.587
2017-01-01
Stem Cell Research
Abstract:Glycogen debranching enzyme (GDE) plays a critical role in glycogenolysis. Mutations in the GDE gene are associated with a metabolic disease known as glycogen storage disease type III (GSDIII). We generated a mutant GDE human embryonic stem cell line, WAe001-A-14, using the CRISPR/Cas9 editing system. This cell line contains a 24-nucleotide deletion within exon-13 of GDE, resulting in 8 amino acids (TRLGISSL) missing of the GDE protein from amino acid position 567 to 575. The WAe001-A-14 cell line maintains typical stem cell morphology, pluripotency and in vitro differentiation potential, and a normal karyotype.